These findings were confirmed by clonogenic assays, which demonstrated a significant reduction in the surviving fraction of MT treated cells (Fig
PubMed laboratory research record [PMID: 41494820] PubMed record related to this compound for laboratory literature review
History of Seizures Contrave can increase the risk of seizures depending on the dose

Major Ingredients Water, Dibutyl Adipate, Butyloctyl Salicylate, Ethylhexyl Triazone, Diethylamino Hydroxybenzoyl Hexyl Benzoate, Propandiol, Niacinamide, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Terephthalylidene Dicamphor Sulfonic Acid, 1,2-Hexanediol, Polyglyceryl-3 Distearate, Ethylhexyl Methoxycrylene, Glycerin, VP/Hexadecene Copolymer, Panthenol, Poly C10-30 Alkyl Acrylate, Sodium Polyacryloyldimethyl Taurate, Tromethamine, Ammonium Polyacryloyldimethyl Taurate, Fragrance, Betaine, Hydroxypropyl Methylcellulose Stearoxy Ether, Glyceryl Stearate Citrate, Glutathione(500ppm), Meltodextrin, Persea Gratissima (Avocado) Fruit Extract, Ethylhexylglycerin, Adenosine, t-Butyl Alcohol, Hydrolyzed Hyaluronic Acid, Thioctic Acid, Brassica Campestris (Rapeseed) Sterols, Cholesterol, PEG-5 Rapeseed Sterol, Ceteth-3, Ceteth-5, Hydrogenated Lecithin, Sodium Ascorbyl Phosphate, Potassium Cetyl Phosphate, Disodium EDTA Ingredients subject to change at manufacturer's discretion
L-
By Merative | 1 min